(2016) 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

(ACCF)/AHA guideline for the management of STEMI4 and the 2014 ACC/AHA guide - line for the management of NSTE-ACS.5 Primary Prevention Acute Coronary Syndrome February 15, 2017 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation 2. KEY MESSAGE (1) Epidemiology of STEMI: Although the rate of mortality associated with ischaemic heart disease have reduced in Europe over the last few decades, this is still the single most common cause of death worldwide. Green LA, Heidenreich PA, Ho PM, Jurgens CY, King ML, Kumbhani DJ, Pancholy S. 2017 AHA/ACC clinical performance and quality measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Part 9: Acute Coronary Syndromes. it is appropriate to follow the ACC/AHA STEMI Guidelines recommendation that PPCI is the preferred reperfusion strategy when time from symptom onset is less than 12 hours and time to PPCI from first medical contact in these patients is anticipated to be less Jneid H, Addison D, Bhatt DL, et al. 2017 AHA/ACC clinical performance and quality measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2017;70(16):2048-2090. • history of myocardial infarction 2016 Addendum to ACC/AHA guideline . Consider adding other agents such as ezetimibe who have less than 50% LDL-C reduction for secondary prevention or PCSK9 inhibitors. Cho